-
公开(公告)号:DK0805812T3
公开(公告)日:2001-09-17
申请号:DK96903364
申请日:1996-01-11
Applicant: ABBOTT LAB
Inventor: BASHA FATIMA Z , TIETJE KARIN R , MEYER MICHAEL D , ALTENBACH ROBERT J , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F JR , LEBOLD SUZANNE A , LEE EDMUND L , PRATT JOHN K , YAMAMOTO DIANE M , SIPPY KEVIN B
IPC: A61K31/505 , A61K31/519 , A61P13/02 , A61P15/00 , A61P25/02 , C07D401/06 , C07D403/06 , C07D471/04 , C07D473/04 , C07D475/02 , C07D487/04 , C07D491/04 , C07D491/056 , C07D495/04 , C07D498/04 , C07D487/02 , C07D487/00 , C07D495/02
Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a bicyclic heterocyclic ring system. The compounds are alpha -1 adrenergic antagonists and are useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 receptors and treating BPH.
-
公开(公告)号:AT194141T
公开(公告)日:2000-07-15
申请号:AT96903340
申请日:1996-01-11
Applicant: ABBOTT LAB
Inventor: MEYER MICHAEL D , ALTENBACH ROBERT J , BASHA FATIMA Z , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F JR , LEBOLD SUZANNE A , LEE EDMUND L , ELMORE STEVEN W , SIPPY KEVIN B , TIETJE KARIN R , WENDT MICHAEL D , YAMAMOTO DIANE M
IPC: A61K31/437 , A61K31/519 , A61P13/00 , A61P13/08 , A61P43/00 , C07D403/06 , C07D471/04 , C07D471/14 , C07D487/04 , C07D487/14 , C07D491/04 , C07D491/048 , C07D491/14 , C07D491/147 , C07D495/04 , C07D495/14 , C07D487/16
Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a tricyclic heterocyclic ring system; which is an alpha -1 adrenergic antagonist and is useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 receptors and treating BPH.
-
公开(公告)号:GR3034485T3
公开(公告)日:2000-12-29
申请号:GR20000402174
申请日:2000-09-26
Applicant: ABBOTT LAB
Inventor: MEYER MICHAEL D , ALTENBACH ROBERT J , BASHA FATIMA Z , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F JR , LEBOLD SUZANNE A , LEE EDMUND L , ELMORE STEVEN W , SIPPY KEVIN B , TIETJE KARIN R , WENDT MICHAEL D , YAMAMOTO DIANE M
IPC: A61K31/437 , A61K31/519 , A61P13/00 , A61P13/08 , A61P43/00 , C07D403/06 , C07D471/04 , C07D471/14 , C07D487/04 , C07D487/14 , C07D491/04 , C07D491/048 , C07D491/14 , C07D491/147 , C07D495/04 , C07D495/14 , C07D487/16 , A61K31/395
Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a tricyclic heterocyclic ring system; which is an alpha -1 adrenergic antagonist and is useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 receptors and treating BPH.
-
公开(公告)号:AU705283B2
公开(公告)日:1999-05-20
申请号:AU4745796
申请日:1996-01-11
Applicant: ABBOTT LAB
Inventor: MEYER MICHAEL D , ALTENBACH ROBERT J , BASHA FATIMA Z , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F JR , LEBOLD SUZANNE A , LEE EDMUND L , ELMORE STEVEN W , SIPPY KEVIN B , TIETJE KARIN R , WENDT MICHAEL D , YAMAMOTO DIANE M
IPC: A61K31/437 , A61K31/519 , A61P13/00 , A61P13/08 , A61P43/00 , C07D403/06 , C07D471/04 , C07D471/14 , C07D487/04 , C07D487/14 , C07D491/04 , C07D491/048 , C07D491/14 , C07D491/147 , C07D495/04 , C07D495/14 , C07D487/16 , A61K31/395
Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a tricyclic heterocyclic ring system; which is an alpha -1 adrenergic antagonist and is useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 receptors and treating BPH.
-
公开(公告)号:AU4745796A
公开(公告)日:1996-08-14
申请号:AU4745796
申请日:1996-01-11
Applicant: ABBOTT LAB
Inventor: MEYER MICHAEL D , ALTENBACH ROBERT J , BASHA FATIMA Z , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F JR , LEBOLD SUZANNE A , LEE EDMUND L , ELMORE STEVEN W , SIPPY KEVIN B , TIETJE KARIN R , WENDT MICHAEL D , YAMAMOTO DIANE M
IPC: A61K31/437 , A61K31/519 , A61P13/00 , A61P13/08 , A61P43/00 , C07D403/06 , C07D471/04 , C07D471/14 , C07D487/04 , C07D487/14 , C07D491/04 , C07D491/048 , C07D491/14 , C07D491/147 , C07D495/04 , C07D495/14 , C07D487/16 , A61K31/395
Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a tricyclic heterocyclic ring system; which is an alpha -1 adrenergic antagonist and is useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 receptors and treating BPH.
-
公开(公告)号:PT808318E
公开(公告)日:2000-12-29
申请号:PT96903340
申请日:1996-01-11
Applicant: ABBOTT LAB
Inventor: BASHA FATIMA Z , ALTENBACH ROBERT J , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F , WENDT MICHAEL D , MEYER MICHAEL D , LEBOLD SUZANNE A , LEE EDMUND L , ELMORE STEVEN W , SIPPY KEVIN B , TIETJE KARIN R , YAMAMOTO DIANE M
IPC: A61K31/437 , A61K31/519 , A61P13/00 , A61P13/08 , A61P43/00 , C07D403/06 , C07D471/04 , C07D471/14 , C07D487/04 , C07D487/14 , C07D491/04 , C07D491/048 , C07D491/14 , C07D491/147 , C07D495/04 , C07D495/14 , C07D487/16 , A61K31/395
Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a tricyclic heterocyclic ring system; which is an alpha -1 adrenergic antagonist and is useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 receptors and treating BPH.
-
公开(公告)号:MX9705675A
公开(公告)日:1997-10-31
申请号:MX9705675
申请日:1996-01-11
Applicant: ABBOTT LAB
Inventor: MEYER MICHAEL D , ALTENBACH ROBERT J , BASHA FATIMA J , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F JR , LEBOLD SUZANNE A , LEE EDMUND L , PRATY JOHN K
IPC: A61K31/505 , A61K31/519 , A61P13/02 , A61P15/00 , A61P25/02 , C07D401/06 , C07D403/06 , C07D471/04 , C07D473/04 , C07D475/02 , C07D487/04 , C07D491/04 , C07D491/056 , C07D495/04 , C07D498/04 , C07D487/02 , C07D495/02 , C07D487/00 , C07D239/00 , C07D209/00 , C07D333/00
Abstract: La presente invencion se refiere a un compuesto de la Formula (I), y a las sales farmacéuticamente aceptables del mismo, en donde W es un sistema de anillo heterocíclico bicíclico. Los compuestos son antagonistas adrenérgicos alfa-1, y son utiles en el tratamiento de hiperplasia prostática benigna; también se describen composiciones antagonistas de alfa-1, y un método para antagonizar receptores de alfa-1, y para el tratamiento de hiperplasia prostática benigna.
-
公开(公告)号:GR3036560T3
公开(公告)日:2001-12-31
申请号:GR20010401414
申请日:2001-09-06
Applicant: ABBOTT LAB
Inventor: MEYER MICHAEL D , ALTENBACH ROBERT J , BASHA FATIMA Z , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F JR , LEBOLD SUZANNE A , LEE EDMUND L , PRATT JOHN K , SIPPY KEVIN B , TIETJE KARIN R , YAMAMOTO DIANE M
IPC: C07D491/056 , C07D495/04 , C07D498/04 , A61K31/505 , A61K31/519 , A61P13/02 , A61P15/00 , A61P25/02 , C07D401/06 , C07D403/06 , C07D471/04 , C07D473/04 , C07D475/02 , C07D487/04 , C07D491/04 , C07D487/02 , C07D495/02 , C07D487/00
Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a bicyclic heterocyclic ring system. The compounds are alpha -1 adrenergic antagonists and are useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 receptors and treating BPH.
-
公开(公告)号:DK0808318T3
公开(公告)日:2000-10-16
申请号:DK96903340
申请日:1996-01-11
Applicant: ABBOTT LAB
Inventor: SIPPY KEVIN B , MEYER MICHAEL D , ALTENBACH ROBERT J , BASHA FATIMA Z , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F JR , LEBOLD SUZANNE A , LEE EDMUND L , ELMORE STEVEN W , TIETJE KARIN R , WENDT MICHAEL D , YAMAMOTO DIANE M
IPC: A61K31/437 , A61K31/519 , A61P13/00 , A61P13/08 , A61P43/00 , C07D403/06 , C07D471/04 , C07D471/14 , C07D487/04 , C07D487/14 , C07D491/04 , C07D491/048 , C07D491/14 , C07D491/147 , C07D495/04 , C07D495/14 , A61K31/395 , C07D487/16
Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a tricyclic heterocyclic ring system; which is an alpha -1 adrenergic antagonist and is useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 receptors and treating BPH.
-
公开(公告)号:CA2211212A1
公开(公告)日:1996-08-01
申请号:CA2211212
申请日:1996-01-11
Applicant: ABBOTT LAB
Inventor: MEYER MICHAEL D , LEE EDMUND L , CARROLL WILLIAM A , LEBOLD SUZANNE A , WENDT MICHAEL D , KERWIN JAMES F JR , YAMAMOTO DIANE M , DRIZIN IRENE , ALTENBACH ROBERT J , SIPPY KEVIN B , ELMORE STEVEN W , TIETJE KARIN R , BASHA FATIMA Z
IPC: A61K31/437 , A61K31/519 , A61P13/00 , A61P13/08 , A61P43/00 , C07D403/06 , C07D471/04 , C07D471/14 , C07D487/04 , C07D487/14 , C07D491/04 , C07D491/048 , C07D491/14 , C07D491/147 , C07D495/04 , C07D495/14 , A61K31/505
Abstract: The present invention relates to a compound of formula (I) and the pharmaceutically acceptable salts thereof wherein W is a tricyclic heterocyclic ring system; which is an .alpha.-1 adrenergic antagonist and is useful in the treatment of BPH; also disclosed are .alpha.-1 antagonist compositions and a method for antagonizing .alpha.-1 receptors and treating BPH.
-
-
-
-
-
-
-
-
-